Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Combination therapy based on dual-target biomimetic nano-delivery system for overcoming cisplatin resistance in hepatocellular carcinoma

Fig. 6

Double target binding ability of AR-NADR. A Fluorescence images of HepG2 (A54 + cell), 4T1, A549, and HeLa cells (A54-cell) incubated with various treatments for 12 h. B Fluorescence images of HepG2 cellular uptake of AR@Ag-MOFs (AR-AM) and AR@NLS-Ag-MOFs (AR-NA) at 2, 6 and 24 h. Scale bar: 50 μm, 20 μm

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us